J&J To Appeal German Stent Patent Suit Ruling In Favor Of Boston Scientific
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson is in the process of filing an appeal of a May 15 German court ruling that its BX Velocity coronary stent infringes patented Boston Scientific NIR stent technology, the firm says. Boston Scientific is seeking an injunction and damages based on sales.